Retrotope‘s proprietary drug platform represents a breakthrough in the treatment of degenerative diseases. Research has established a link between the oxidative damage of lipids in mitochondrial membranes and neurodegeneration in Parkinson’s, Alzheimer’s, Friedreich’s ataxia and other diseases. Retrotope’s first drug candidate, RT001, confers cell protection against oxidative stress in high energy tissues like brain, retina and heart tissue by inhibiting mitochondrial lipid peroxidation. Its mechanism of action has been shown not only to prevent further cellular damage but also to recover mitochondrial function. RT001’s molecular structure is so similar to ordinary fats that the body naturally distributes them throughout the tissues wherever they are needed. The drug has been determined safe in human trials in a recent Phase 1/2 clinical trial in Friedreich’s ataxia patients. Retrotope is a privately held company founded and backed by world—renowned scientists, entrepreneurs, and investors. The company founders have dozens of years of experience in drug discovery technologies, a member of the US National Academy of Sciences, and several successful startups among them. Retrotope has developed its science virtually, with over 50 collaborations at major centers of excellence around the world that have yielded insights into the mechanisms of several diseases.
View Top Employees from Retrotope, Inc.Website | http://www.retrotope.com |
Revenue | $7 million |
Funding | $37.3 million |
Employees | 9 (7 on RocketReach) |
Founded | 2006 |
Address | 4300 El Camino Real, Los Altos, California 94022, US |
Phone | (650) 917-9256 |
Technologies |
JavaScript,
HTML,
PHP
+13 more
(view full list)
|
Industry | Drug Discovery, Pharmaceutical Manufacturing, Drug Manufacturing & Research, Biotechnology, Pharmaceuticals, Science and Engineering, Discovery Tools (Healthcare), Healthcare, Health Care, Medical |
Web Rank | 12 Million |
Keywords | Retrotope, Retrotope Inc., Rt 001 Clinical Trial, Retrotope Inc |
SIC | SIC Code 283 Companies, SIC Code 28 Companies |
NAICS | NAICS Code 3254 Companies, NAICS Code 32541 Companies, NAICS Code 325 Companies, NAICS Code 32 Companies |
Looking for a particular Retrotope, Inc. employee's phone or email?
The Retrotope, Inc. annual revenue was $7 million in 2024.
Frederic Heerinckx is the Vice President Clinical Operations of Retrotope, Inc..
7 people are employed at Retrotope, Inc..
Retrotope, Inc. is based in Los Altos, California.
The NAICS codes for Retrotope, Inc. are [3254, 32541, 325, 32].
The SIC codes for Retrotope, Inc. are [283, 28].